Literature DB >> 19088937

Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms.

William E Fisher1, Sally E Hodges, Vivek Yagnik, Fannie E Morón, Meng-Fen Wu, Susan G Hilsenbeck, Isaac L Raijman, F Charles Brunicardi.   

Abstract

BACKGROUND: Cystic lesions of the pancreas are being identified more frequently. Deciding which asymptomatic lesions can be safely followed with serial imaging and which require resection due to malignant potential is an increasingly common question. Current clinical practice is to rely on characteristics of the lesions on CT scan, and additional information from endoscopic ultrasound with fine-needle aspiration (EUS-FNA) and cyst fluid analysis or endoscopic retrograde pancreatography (ERCP) to assess malignant potential. HYPOTHESIS: The malignant potential of pancreatic cystic lesions cannot be accurately predicted by CT scan.
METHODS: CT scans from 48 patients with cystic lesions of the pancreas were stripped of patient identifiers and retrospectively presented to two expert radiologists. The radiologists recorded specific characteristics of the lesions thought to be important in the differential diagnosis and their opinion of the likely diagnosis. Diagnostic accuracy was assessed by comparing the radiologists' diagnoses to the final pathologic diagnosis after resection. To determine if clinical history, EUS-FNA or ERCP findings improved diagnostic accuracy, medical records were retrospectively reviewed and scored as either supporting or not supporting malignant potential of the lesion.
RESULTS: Specific diagnoses based on CT findings alone were correct in an average of 39% of the cases. Even when diagnoses were dichotomized as benign (43%) or potentially malignant (57%, papillary mucinous neoplasms, mucinous cystic neoplasms, cancer), determinations based on CT alone were accurate in an average of 61% of cases. Accuracy rates were 60.4 and 62.5% for the two radiologists, although there was only fair agreement between them (Kappa=0.28, 95% CI=(0.01-0.55), p=0.05). When all clinical information available was considered together as a single dichotomous indicator of malignant potential, the indicator was accurate in 90% of the cases (Kappa=0.73, 95% CI=(0.51-0.95, p<0.0001)).
CONCLUSION: Specific preoperative diagnosis of pancreatic cystic neoplasms by CT alone is substantially inaccurate. Complementary tests such as EUS-FNA with fluid analysis and ERCP should be recommended to improve diagnosis especially if nonoperative treatment is planned.

Entities:  

Keywords:  computed tomography; cystic neoplasm; pancreatic neoplasm

Year:  2008        PMID: 19088937      PMCID: PMC2597321          DOI: 10.1080/13651820802291225

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

1.  Prospective preoperative determination of mucinous pancreatic cystic neoplasms.

Authors:  R Matthew Walsh; J Michael Henderson; David P Vogt; Mark E Baker; Charles M O'malley; Brian Herts; Gregory Zuccaro; John J Vargo; John A Dumot; Darwin L Conwell; Charles V Biscotti; Nancy Brown
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

2.  Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Authors:  Carlos Fernández-del Castillo; Javier Targarona; Sarah P Thayer; David W Rattner; William R Brugge; Andrew L Warshaw
Journal:  Arch Surg       Date:  2003-04

3.  An aggressive surgical approach is warranted in the management of cystic pancreatic neoplasms.

Authors:  Jeffrey M Hardacre; Michael F McGee; Thomas A Stellato; James A Schulak
Journal:  Am J Surg       Date:  2007-03       Impact factor: 2.565

4.  Natural history of indeterminate pancreatic cysts.

Authors:  R Matthew Walsh; David P Vogt; J Michael Henderson; Gregory Zuccaro; John Vargo; John Dumot; Brian Herts; Charles V Biscotti; Nancy Brown
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

5.  Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years.

Authors:  Brian K P Goh; Yu-Meng Tan; Peng-Chung Cheow; Yaw-Fui Alexander Chung; Pierce K H Chow; Wai-Keong Wong; London L P J Ooi
Journal:  Am J Surg       Date:  2006-08       Impact factor: 2.565

6.  Characterization of cystic pancreatic masses: relative accuracy of CT and MRI.

Authors:  Brendan C Visser; Benjamin M Yeh; Aliya Qayyum; Lawrence W Way; Charles E McCulloch; Fergus V Coakley
Journal:  AJR Am J Roentgenol       Date:  2007-09       Impact factor: 3.959

7.  Cystic pancreatic neoplasms: observe or operate.

Authors:  Kristine S Spinelli; Travis E Fromwiller; Roger A Daniel; James M Kiely; Attila Nakeeb; Richard A Komorowski; Stuart D Wilson; Henry A Pitt
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

8.  Pancreatic cystadenoma and cystadenocarcinoma.

Authors:  L von Segesser; A Rohner
Journal:  Br J Surg       Date:  1984-06       Impact factor: 6.939

9.  Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients.

Authors:  Peter J Allen; David P Jaques; Michael D'Angelica; Wilbur B Bowne; Kevin C Conlon; Murray F Brennan
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.452

10.  Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

Authors:  William R Brugge; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; Barbara A Centeno; Tara Szydlo; Susan Regan; Carlos Fernandez del Castillo; Andrew L Warshaw
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  22 in total

1.  Computed tomography reflected endocrine function of the pancreas.

Authors:  Naoaki Sakata; Shinichi Egawa; Toshiki Rikiyama; Gumpei Yoshimatsu; Kunihiro Masuda; Hideo Ohtsuka; Shigeru Ottomo; Kei Nakagawa; Hiroki Hayashi; Takanori Morikawa; Tohru Onogawa; Kuniharu Yamamoto; Hiroshi Yoshida; Masanori Akada; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Michiaki Unno
Journal:  J Gastrointest Surg       Date:  2010-12-23       Impact factor: 3.452

2.  Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons.

Authors:  Hans G Beger
Journal:  J Gastrointest Surg       Date:  2018-01-03       Impact factor: 3.452

Review 3.  Pancreatic cystic lesions: when to watch, when to operate, and when to ignore.

Authors:  Brian G Turner; William R Brugge
Journal:  Curr Gastroenterol Rep       Date:  2010-04

4.  Imaging of benign and malignant cystic pancreatic lesions and a strategy for follow up.

Authors:  Priya Bhosale; Aparna Balachandran; Eric Tamm
Journal:  World J Radiol       Date:  2010-09-28

5.  Diagnostic and therapeutic endoscopic approaches to intraductal papillary mucinous neoplasm.

Authors:  Brian G Turner; William R Brugge
Journal:  World J Gastrointest Surg       Date:  2010-10-27

6.  Clinical factors predictive of malignant and premalignant cystic neoplasms of the pancreas: a single institution experience.

Authors:  Natalie B Jones; Ioannis Hatzaras; Nathaniel George; Peter Muscarella; E Christopher Ellison; W Scott Melvin; Mark Bloomston
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

7.  Spontaneous Rupture of the Main Pancreatic Duct Synchronous With a Multi-Focal Microscopic Pancreatic Adenocarcinoma: A Case Report.

Authors:  Shirly Shohat; Katerina Shulman; Boris Kessel; Oren Gal; Abdel Rauf Zeina
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 8.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 9.  Radiological Workup of Cystic Neoplasms of the Pancreas.

Authors:  Thomas L Bollen; Frank J Wessels
Journal:  Visc Med       Date:  2018-06-15

10.  Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery.

Authors:  E S Huang; B G Turner; C Fernandez-Del-Castillo; W R Brugge; C Hur
Journal:  Aliment Pharmacol Ther       Date:  2009-10-21       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.